Subsequently, we investigated the expression patterns of the 10 DRGs in control and NAFLD samples (Figure 2A), and the results showed that NCKAP1 was significantly highly expressed in NAFLD samples, while SLC3A2 was lowly expressed in NAFLD samples (Figure 2B). Here, SLC3A2 is linked to metabolic dysfunction-associated steatotic liver disease.